Literature DB >> 7554474

Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: effect of corticosteroids.

H Hogenesch1, P W Snyder, J C Scott-Moncrieff, L T Glickman, P J Felsburg.   

Abstract

Juvenile polyarteritis syndrome (JPS) is an idiopathic febrile disease in dogs. Elevated serum levels of interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) have been reported in human patients with vasculitis. We investigated whether these cytokines are also elevated in serum of dogs with JPS using sensitive bioassays. Increased levels of IL-6 activity were detected in the serum of 12 acutely ill dogs, whereas the IL-6 activity decreased to low or undetectable levels during convalescence. Treatment of 5 acute JPS dogs with prednisone resulted in a rapid clinical improvement accompanied by a decrease of IL-6 activity. Withdrawal of prednisone treatment caused reappearance of clinical symptoms and high serum IL-6 activity within a few days. TNF activity could not be detected in the samples of normal dogs, convalescent JPS, or acute JPS dogs. These studies support a role for IL-6 in the pathogenesis of JPS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554474     DOI: 10.1016/0090-1229(95)90143-4

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  3 in total

1.  High Fever induced by dexamethasone withdrawal.

Authors:  L Margolin; R Bakst-Sisser; M Segal; J Nissinoff; M Thomas
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

2.  Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis.

Authors:  Arianna Maiolini; Meike Otten; Marion Hewicker-Trautwein; Regina Carlson; Andrea Tipold
Journal:  BMC Vet Res       Date:  2013-02-04       Impact factor: 2.741

3.  Immune-mediated fever in the dog. Occurrence of antinuclear antibodies, rheumatoid factor, tumor necrosis factor and interleukin-6 in serum.

Authors:  J Ovrebø Bohnhorst; I Hanssen; Torolf Moen
Journal:  Acta Vet Scand       Date:  2002       Impact factor: 1.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.